QuantPharm LLC is a consulting company specializing in advanced quantitative modeling, simulation, drug development and clinical pharmacology consulting to support pharmaceutical and biotechnology industries. QuantPharmTM offers fast, efficient and high quality population analysis of pharmacokinetic and pharmacodynamic data and model-based clinical trial simulations to support all stages of drug development, from pre-clinical to Phase IV.
Leonid Gibiansky, the founder and the president of QuantPharm LLC, has more than 25 years of academic and industry experience in areas as diverse as pharmacometrics, PK-PD modeling and simulation, in vitro-in vivo correlations, statistical design and analysis of clinical trials, statistical algorithm design and software development, bioinformatics, and optimization in mathematical physics.
Ekaterina Gibiansky, CEO and CSO of QuantPharm LLC, started her pharmaceutical industry career in 1992 in the first-in-industry modeling and simulation group in Novartis and subsequently worked in small and large pharmaceutical companies, biotechnology companies, and consulting companies. She has broad drug development and modeling expertise and the extensive experience interacting with clinical teams, advisory boards, and the FDA.
Strict confidentiality, scientific expertise and integrity, high efficiency and close collaboration with the sponsor form the foundation of our services.